G protein–coupled receptors ( GPCRs ) which are also known as seven-transmembrane domain receptors , 7TM receptors , heptahelical receptors , serpentine receptor , and G protein–linked receptors ( GPLR ), constitute a large protein family of receptors , that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses.
Asia Pacific region is expected to grow at a significant rate during the forecast period owing to the economic development of the countries such as China and India owing to increasing government investment in the biotechnology and biopharmaceutical sector, increasing life expectancy, rising per capita income and unmet market needs in the region.

The global G-Protein Coupled Receptors (GPCRs) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on G-Protein Coupled Receptors (GPCRs) volume and value at global level, regional level and company level. From a global perspective, this report represents overall G-Protein Coupled Receptors (GPCRs) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of G-Protein Coupled Receptors (GPCRs) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their G-Protein Coupled Receptors (GPCRs) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Thermo Fisher Scientific, Inc
EMD (Merck) Millipore
PerkinElmer, Inc
Cisbio Bioassays
Enzo Life Sciences, Inc.
DiscoveRx Corporation
Promega Corporation
Abcam plc
HD Biosciences Co. Ltd.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Pharmaceutical
Biopharmaceutical

Segment by Application
Immune System Disease
Oncology Disease
Other Disease